Core Scientific (CORZ) Cash from Investing Activities (2021 - 2026)

Core Scientific has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$386.7 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$386.7 million, down 334.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 582.08% YoY), and the FY2025 annual result was -$740.8 million, down 678.16% from the prior year.
• Cash from Investing Activities came in at -$386.7 million for Q1 2026 at Core Scientific, down from -$277.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2023 to a low of -$386.7 million in Q1 2026.
• The 5-year median for Cash from Investing Activities is -$32.0 million (2024), against an average of -$106.8 million.
• Across the five-year window, Cash from Investing Activities surged 101.69% in 2023 and plunged 3656.53% in 2025, its largest moves.
• Core Scientific's Cash from Investing Activities stood at -$139.5 million in 2022, then soared by 101.69% to $2.4 million in 2023, then tumbled by 1320.25% to -$28.8 million in 2024, then tumbled by 864.54% to -$277.8 million in 2025, then tumbled by 39.2% to -$386.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$386.7 million (Q1 2026), -$277.8 million (Q4 2025), and -$254.4 million (Q3 2025), per Business Quant data.